Product Information
PAXIL 20 MG TABLET is a brand product labeled by Apotex Corp., priced at $10.7372 per EA under NDC 60505451803. Its NADAC has been published 221 times since Apr 10, 2019.
FDA first approved this application on Dec 29, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the paroxetine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/1
Manufacturer
Apotex Corp.NDC
60505451803
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PAROXETINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020031FDA Approved
12/29/1992
TE Code
AB
On Market Since
3/11/2019
Pharmacological Classes
Price Statistics
The NADAC for PAXIL 20 MG TABLET has been published 221 times since Apr 10, 2019, and over the history we have for it it has risen 72.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.7372 per EA |
|---|---|
| All-time high | $10.7661 (Jun 10, 2026) |
| All-time low | $6.2399 (Apr 10, 2019) |
| 52-week high | $10.7661 |
| 52-week low | $10.6618 |
| Median price | $7.0444 |
| Average price | $8.2795 |
| Largest weekly change | +27.5% (Apr 17, 2024) |
| Weeks tracked | 221 |
| Tracking since | Apr 10, 2019 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
paroxetine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PAXIL 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAXIL 20 MG TABLET, manufactured by Apotex Corp., is $10.7372 per EA (NDC 60505451803), effective Sep 30, 2026.
How has the price of PAXIL 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAXIL 20 MG TABLET has risen 72.1%. It has been tracked across 221 weekly CMS publications since Apr 10, 2019.
What are the highest and lowest recorded NADAC prices for PAXIL 20 MG TABLET?
Since Apr 10, 2019, the NADAC for PAXIL 20 MG TABLET has ranged from a low of $6.2399 (Apr 10, 2019) to a high of $10.7661 (Jun 10, 2026), with a median of $7.0444 per EA.
Are there cheaper alternatives to PAXIL 20 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PAROXETINE HCL 20 MG TABLET, is $0.0611 per EA — about 99% below PAXIL 20 MG TABLET.
Who manufactures PAXIL 20 MG TABLET?
PAXIL 20 MG TABLET (NDC 60505451803) is labeled by Apotex Corp., and CMS classifies it as a brand product.